BlossomHill Therapeutics
Sarah Wheeler, BS, CCRA, has extensive experience in clinical operations, holding various leadership roles over the years. Currently serving as Executive Director of Clinical Operations at BlossomHill Therapeutics, Inc. and previously in similar positions at NiKang Therapeutics Inc. and Turning Point Therapeutics. Sarah's career also includes roles as Director of Clinical Operations at eFFECTOR Therapeutics, Inc. and Assistant Director at Isis Pharmaceuticals. Academic credentials include a Bachelor of Science in Health Science from San Diego State University and studies at the University of California, Santa Cruz.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.